New data for Arexvy, GSK’s RSV vaccine, show potential to help protect adults aged 50 to 59 at increased risk for RSV disease Read more
Clinical Trial Application (IND) for BioRay Pharmaceutical’s BR105 Injection Receives U.S. FDA Approval Read more
Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism Read more
Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics Read more
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets Read more
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development Read more
TiumBio and Hansoh Pharma Announce Clinical Trial Approval of ‘HS-10518/TU2670’ from NMPA in China Read more
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China Read more
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer Read more
The Bristol Myers Squibb-Janssen Collaboration Launches Pivotal Phase 3 Librexia Clinical Trial Program Evaluating Milvexian, an Investigational Oral Factor XIa Inhibitor Read more